Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombectomy | 11 | 2020 | 235 | 3.090 |
Why?
|
| Intracranial Embolism | 4 | 2020 | 39 | 1.390 |
Why?
|
| Embolization, Therapeutic | 5 | 2019 | 321 | 1.310 |
Why?
|
| Thrombosis | 4 | 2019 | 199 | 1.260 |
Why?
|
| Models, Anatomic | 4 | 2018 | 64 | 1.170 |
Why?
|
| Catheters | 2 | 2019 | 75 | 1.150 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2018 | 86 | 1.060 |
Why?
|
| Stroke | 13 | 2019 | 1196 | 0.990 |
Why?
|
| Device Removal | 2 | 2016 | 68 | 0.910 |
Why?
|
| Stents | 5 | 2016 | 502 | 0.880 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2019 | 47 | 0.670 |
Why?
|
| Neuronavigation | 1 | 2018 | 13 | 0.590 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2017 | 24 | 0.520 |
Why?
|
| Brain Ischemia | 7 | 2019 | 419 | 0.510 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 214 | 0.480 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 284 | 0.460 |
Why?
|
| Treatment Outcome | 11 | 2020 | 5680 | 0.380 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2019 | 74 | 0.370 |
Why?
|
| Intracranial Aneurysm | 2 | 2014 | 367 | 0.340 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 2187 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 2172 | 0.310 |
Why?
|
| Blood Platelets | 2 | 2019 | 102 | 0.280 |
Why?
|
| Cerebrovascular Disorders | 2 | 2019 | 81 | 0.260 |
Why?
|
| Cerebral Revascularization | 3 | 2019 | 30 | 0.240 |
Why?
|
| Catheterization | 2 | 2018 | 111 | 0.240 |
Why?
|
| Cerebral Angiography | 3 | 2016 | 293 | 0.220 |
Why?
|
| Cerebrovascular Circulation | 3 | 2014 | 181 | 0.220 |
Why?
|
| Humans | 16 | 2020 | 63445 | 0.190 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2014 | 126 | 0.190 |
Why?
|
| Cattle | 2 | 2019 | 310 | 0.170 |
Why?
|
| Evaluation Studies as Topic | 1 | 2020 | 104 | 0.170 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2020 | 186 | 0.160 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2019 | 8 | 0.160 |
Why?
|
| Equipment Design | 1 | 2020 | 352 | 0.160 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 46 | 0.150 |
Why?
|
| Biomechanical Phenomena | 1 | 2019 | 270 | 0.150 |
Why?
|
| Staining and Labeling | 1 | 2019 | 126 | 0.140 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2019 | 109 | 0.140 |
Why?
|
| Endovascular Procedures | 2 | 2015 | 655 | 0.140 |
Why?
|
| Thromboembolism | 2 | 2019 | 73 | 0.130 |
Why?
|
| Dogs | 2 | 2019 | 325 | 0.130 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2017 | 70 | 0.130 |
Why?
|
| Animals | 8 | 2019 | 20660 | 0.120 |
Why?
|
| Shear Strength | 1 | 2015 | 16 | 0.120 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2015 | 8 | 0.120 |
Why?
|
| Permeability | 1 | 2014 | 49 | 0.110 |
Why?
|
| Particle Size | 1 | 2016 | 407 | 0.110 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2014 | 45 | 0.110 |
Why?
|
| Equipment Failure | 1 | 2014 | 67 | 0.100 |
Why?
|
| Radiology, Interventional | 1 | 2014 | 32 | 0.100 |
Why?
|
| Materials Testing | 1 | 2014 | 85 | 0.100 |
Why?
|
| Device Approval | 1 | 2013 | 13 | 0.100 |
Why?
|
| Radiography, Interventional | 1 | 2014 | 75 | 0.100 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2013 | 134 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2013 | 89 | 0.100 |
Why?
|
| Safety | 1 | 2013 | 145 | 0.100 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 169 | 0.100 |
Why?
|
| Mechanical Thrombolysis | 1 | 2012 | 37 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1654 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1644 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2015 | 513 | 0.080 |
Why?
|
| Erythrocytes | 2 | 2019 | 149 | 0.070 |
Why?
|
| Male | 7 | 2019 | 29888 | 0.070 |
Why?
|
| Brain | 1 | 2015 | 1552 | 0.070 |
Why?
|
| Female | 6 | 2019 | 32877 | 0.060 |
Why?
|
| Risk Factors | 1 | 2014 | 5353 | 0.060 |
Why?
|
| Rabbits | 2 | 2015 | 333 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 5461 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 373 | 0.050 |
Why?
|
| Radiography | 2 | 2014 | 550 | 0.040 |
Why?
|
| United States | 1 | 2013 | 7845 | 0.040 |
Why?
|
| Clot Retraction | 1 | 2019 | 3 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2019 | 33 | 0.040 |
Why?
|
| Coronary Thrombosis | 1 | 2019 | 21 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 179 | 0.040 |
Why?
|
| Fibrin | 1 | 2019 | 19 | 0.040 |
Why?
|
| Machine Learning | 1 | 2019 | 177 | 0.030 |
Why?
|
| Aged | 3 | 2019 | 14445 | 0.030 |
Why?
|
| Adult | 3 | 2019 | 16823 | 0.030 |
Why?
|
| Middle Aged | 3 | 2019 | 17611 | 0.030 |
Why?
|
| Echoencephalography | 1 | 2015 | 13 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 888 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2015 | 62 | 0.030 |
Why?
|
| Molecular Imaging | 1 | 2015 | 48 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 208 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 2014 | 11 | 0.030 |
Why?
|
| Injections, Intra-Arterial | 1 | 2014 | 21 | 0.030 |
Why?
|
| Arteriovenous Malformations | 1 | 2014 | 43 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 490 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2014 | 153 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 222 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 671 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 1980 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 190 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4694 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6657 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 3768 | 0.020 |
Why?
|